The Effect of Exercise at Different Time Intervals on Hyperuricemia
NCT06315569 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2025-04-03
Summary
The study aim is to explore the correlation between exercise and hyperuricemia, find out the metabolic rule of uric acid after exercise, and provide scientific evidence and clinical guidance for how to exercise scientifically and reasonably in patients with hyperuricemia. This trial is a multicenter, prospective, randomized controlled clinical trial with 100 participants. Inclusion criteria: 1. Patients with hyperuricemia (fasting uric acid \> 420μmol/L twice on different days); 2. Men aged between 18 and 35; 3. Able to complete baseline fitness test (3000m run time less than 14 minutes); 4. Fully informed consent, signed informed consent exclusion criteria: 1. Patients with heart, liver and kidney insufficiency. 2. Subjects suffering from severe or uncontrollable organic diseases may interfere with study parameters such as hypertension, hyperlipidemia, hyperglycemia, tumor, cardiovascular, lung and digestive diseases. 3. Patients with secondary hyperuricemia caused by other diseases. 4. Take any drugs that may cause uric acid changes in the past 4 weeks. 5. Those who have related motor function or other factors are easy to cause discomfort after exercise. 6. Those who have mental illness or communicate do not cooperate during the test.
A total of 100 participants participated in the study(Group A n = 50 ; Group B n = 50 ). The subjects are divided into two groups, designated as A and B. Following the completion of the grouping, all subjects complete the initial 3000 m run. The second 3000 m run is performed on the seventh day following the initial run. The interval between the third run and the second run in Group A is 24 hours, while the interval in Group B is 48 hours. During the 48-hour observation period after each exercise, the changes of uric acid after exercise were explored. To provide scientific evidence and clinical guidance for patients with hyperuricemia how to exercise scientifically and rationally.
Patients must meet all inclusion and exclusion criteria to be eligible to participate in the study. After determining patients' eligibility for the study, the researcher should fully explain the nature, purpose, risks and benefits of the study to the subjects before the study, and assure the patients that they have the right to withdraw at any time after agreeing to participate in the study, and the subjects should sign a written informed consent after fully considering and agreeing to participate in the study. The process of obtaining informed consent should be correctly recorded in all case report forms in this study.
Baseline data such as blood uric acid, blood biochemistry, blood routine, urine routine, uric acid, and demographic characteristics were collected after the patients were enrolled.
The patients were randomly divided into two groups: Group A and Group B. Within 48 hours after each 3000m exercise, the subjects' blood uric acid was detected after exercise 1 hour, 2 hours, 3 hours, 12 hours, 24 hours, 36 hours, 48 hours.
From January 2024 to February 2024, we plan to draft clinical study protocols, investigator manuals, case reports, informed consent forms and other documents, and submit them to the Ethics Committee of the research sponsor for review and approval; February 2024 - March 2024: Complete the training of all researchers and officially start the research; March 2024 - August 2024: Participants were enrolled for the experiment; August 2024 - November 2024: collate and collect data, conduct statistical analysis, and confirm research results
Conditions
- Hyperuricemia
Interventions
- BEHAVIORAL
-
Run 3000 meters
Participants in both groups were asked to do two 3,000-meter runs at different intervals
Sponsors & Collaborators
-
Xijing Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 35 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-05-24
- Primary Completion
- 2025-02-27
- Completion
- 2025-02-27
Countries
- China
Study Locations
More Related Trials
-
Effects of Barley Green in Patients With Hyperuricemia
NCT04438486 ·Status: UNKNOWN ·Phase: NA
-
A Prospective Cohort Study of China Serum Uric Acid Levels
NCT03616769 ·Status: COMPLETED
-
The Drug-Drug Interaction of SHR4640 and Febuxostat in Patients With Hyperuricemia
NCT04157959 ·Status: UNKNOWN ·Phase: PHASE1
-
Screening and Management of Hyperuricemia in Patients with Chronic Medical Diseases in Assiut University Hospital
NCT06586229 ·Status: NOT_YET_RECRUITING
-
Hyperuricemia on Hypertension and Metabolic Syndrome
NCT01157936 ·Status: COMPLETED ·Phase: PHASE2
-
Musculoskeletal Ultrasound in Asymptomatic Hyperuricemia
NCT02502565 ·Status: UNKNOWN
-
Tolerance, Pharmacokinetics / Pharmacodynamics (PK / PD) and Immunogenicity of Pegylated Uric Acid Oxidase for Injection in Healthy Adults and Hyperuricemia Volunteers
NCT05226013 ·Status: UNKNOWN ·Phase: PHASE1
-
The Efficiency and Safety of Sodium Bicarbonate on Uric Acid in Patients With Asymptomatic Hyperuricemia or Gout
NCT03306758 ·Status: UNKNOWN ·Phase: NA
-
Evaluating the Effectiveness of a Chronic Disease Management Program for Gout
NCT01568879 ·Status: COMPLETED ·Phase: NA
-
Hyperuricemia and Diabetic Nephropathy
NCT04799925 ·Status: UNKNOWN
-
Effect of Hyperuricaemia on Chronic Renal Disease
NCT03425708 ·Status: UNKNOWN ·Phase: PHASE4
-
The Efficacy of Amway Uric Acid Lowering Product on Hyperuricemia
NCT06084585 ·Status: RECRUITING ·Phase: NA
-
Prebiotics and the Management of Hyperuricemia
NCT06420401 ·Status: RECRUITING ·Phase: NA
-
Prednisone for Heart Failure Patients With Hyperuricemia
NCT02129764 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Dose-finding and Safety Study of SHR4640 in Subjects With Hyperuricemia
NCT03185793 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetic Study of Marine Active in Health Men
NCT00207974 ·Status: UNKNOWN ·Phase: PHASE1
-
Study of FYU-981 in Hyperuricemia (Effect on Two Hyperuricemic Types)
NCT02837198 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized Clinical Trail of The Effect of Postoperative Uric Acid Control on Stone Recurrence and Renal Function in Patients With Hyperuricemia of Urolithiasis.
NCT04398251 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study of the Efficacy of Genakumab in Prevention of Acute Flares in Gout Patients Initiating Urate-lowering TherapyUrate-lowering (GenSci048-202)
NCT05936281 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy Study of Acupuncture on Asymptomatic Hyperuricemia
NCT05406830 ·Status: RECRUITING ·Phase: NA
-
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Oral F-02-2-Na Tablets in Adult Subjects
NCT07324434 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1
-
The Influence of Urate-lowering Therapy on Sperm Quality of Male Gouty Patients:A Prospective Cohort Study
NCT04213534 ·Status: UNKNOWN
-
Study of FYU-981 in Hyperuricemia With or Without Gout
NCT02344862 ·Status: COMPLETED ·Phase: PHASE2
-
The Diet Gout Trial
NCT03569020 ·Status: COMPLETED ·Phase: NA
-
Genetics of Hyperuricemia Therapy in Hmong
NCT02371421 ·Status: COMPLETED